These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34647140)

  • 61. Improved technology satisfaction and sleep quality with Medtronic MiniMed® Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with Type 1 Diabetes in a randomized crossover trial.
    Wheeler BJ; Collyns OJ; Meier RA; Betts ZL; Frampton C; Frewen CM; Galland B; Hewapathirana NM; Jones SD; Chan DSH; Roy A; Grosman B; Kurtz N; Shin J; Vigersky RA; de Bock MI
    Acta Diabetol; 2022 Jan; 59(1):31-37. PubMed ID: 34453208
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.
    Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Type 1 diabetes woman with repeated miscarriages successfully gave birth after introducing an insulin pump with a predictive low glucose suspend feature.
    Honoki H; Yagi K; Tsuda S; Wada T; Enkaku A; Nakagawa-Yokoyama M; Kamigishi M; Shikata M; Takikawa-Nishiday A; Fujisaka S; Chujo D; Sasaoka T; Nakashima A; Saito S; Tobe K
    Diabetol Int; 2021 Jul; 12(3):324-329. PubMed ID: 34150440
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sensor-Augmented Insulin Pump with Predictive Low-Glucose Suspend (PLGS): Determining Optimal Settings of Pump and Sensor in a Multicenter Cohort of Patients with Type 1 Diabetes.
    Joubert M; Briant AR; Kessler L; Fall-Mostaine F; Dubois S; Guerci B; Schoumacker-Ley L; Reznik Y; Parienti JJ
    Diabetes Ther; 2022 Sep; 13(9):1645-1657. PubMed ID: 35913656
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.
    Verbeeten KC; Perez Trejo ME; Tang K; Chan J; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML;
    Pediatr Diabetes; 2021 Mar; 22(2):288-293. PubMed ID: 33179818
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dual-hormone artificial pancreas for glucose control in type 1 diabetes: A meta-analysis.
    Zeng B; Jia H; Gao L; Yang Q; Yu K; Sun F
    Diabetes Obes Metab; 2022 Oct; 24(10):1967-1975. PubMed ID: 35638377
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.
    Battelino T; Conget I; Olsen B; Schütz-Fuhrmann I; Hommel E; Hoogma R; Schierloh U; Sulli N; Bolinder J;
    Diabetologia; 2012 Dec; 55(12):3155-62. PubMed ID: 22965294
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.
    Sherr JL; Palau Collazo M; Cengiz E; Michaud C; Carria L; Steffen AT; Weyman K; Zgorski M; Tichy E; Tamborlane WV; Weinzimer SA
    Diabetes Care; 2014; 37(3):773-9. PubMed ID: 24170766
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MiniMed 780GTM in children with type 1 diabetes under seven years of age: Prospective open-label, single-arm, double-center, follow-up study.
    Seget S; Chobot A; Rusak E; Ochab A; Bielawska A; Polanska J; Jarosz-Chobot P
    Technol Health Care; 2024; 32(3):1463-1472. PubMed ID: 37781828
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia.
    Buckingham BA; Cameron F; Calhoun P; Maahs DM; Wilson DM; Chase HP; Bequette BW; Lum J; Sibayan J; Beck RW; Kollman C
    Diabetes Technol Ther; 2013 Aug; 15(8):622-7. PubMed ID: 23883408
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Breastfeeding at night is rarely followed by hypoglycaemia in women with type 1 diabetes using carbohydrate counting and flexible insulin therapy.
    Ringholm L; Roskjær AB; Engberg S; Andersen HU; Secher AL; Damm P; Mathiesen ER
    Diabetologia; 2019 Mar; 62(3):387-398. PubMed ID: 30607466
    [TBL] [Abstract][Full Text] [Related]  

  • 75. AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol.
    Lee TTM; Collett C; Man MS; Hammond M; Shepstone L; Hartnell S; Gurnell E; Byrne C; Scott EM; Lindsay RS; Morris D; Brackenridge A; Dover AR; Reynolds RM; Hunt KF; McCance DR; Barnard-Kelly K; Rankin D; Lawton J; Bocchino LE; Sibayan J; Kollman C; Wilinska ME; Hovorka R; Murphy HR;
    BMC Pregnancy Childbirth; 2022 Apr; 22(1):282. PubMed ID: 35382796
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
    Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump.
    Viñals C; Mesa A; Roca D; Vidal M; Pueyo I; Conget I; Giménez M
    Acta Diabetol; 2021 Mar; 58(3):383-388. PubMed ID: 33125525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.